Your browser doesn't support javascript.
loading
Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery.
Fuchs, Natalie; Meta, Mergim; Schuppan, Detlef; Nuhn, Lutz; Schirmeister, Tanja.
Affiliation
  • Fuchs N; Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University of Mainz, Staudingerweg 5, D, 55128 Mainz, Germany.
  • Meta M; Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University of Mainz, Staudingerweg 5, D, 55128 Mainz, Germany.
  • Schuppan D; Institute of Translational Immunology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Obere Zahlbacher Str. 63, 55131 Mainz, Germany.
  • Nuhn L; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
  • Schirmeister T; Max Planck Institute for Polymer Research Ackermannweg 10, 55128 Mainz, Germany.
Cells ; 9(9)2020 09 02.
Article in En | MEDLINE | ID: mdl-32887380
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / Cathepsins / Gene Expression Regulation, Neoplastic / Nanoparticles / Tumor-Associated Macrophages / Neoplasms Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / Cathepsins / Gene Expression Regulation, Neoplastic / Nanoparticles / Tumor-Associated Macrophages / Neoplasms Language: En Year: 2020 Type: Article